ROLE OF GLP-1 AGONISTS IN THE TREATMENT OF OBESITY-RELATED GASTROINTESTINAL DISORDERS. The Research of Medical Science Review, [S. l.], v. 3, n. 4, p. 1205–1214, 2025. Disponível em: https://medicalsciencereview.com/index.php/Journal/article/view/1966.. Acesso em: 12 oct. 2026.